0001628280-24-025893.txt : 20240530
0001628280-24-025893.hdr.sgml : 20240530
20240530174410
ACCESSION NUMBER: 0001628280-24-025893
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240528
FILED AS OF DATE: 20240530
DATE AS OF CHANGE: 20240530
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schaeffer Orlov S Nicole
CENTRAL INDEX KEY: 0001401017
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30739
FILM NUMBER: 241006899
MAIL ADDRESS:
STREET 1: INSMED INCORPORATED
STREET 2: 700 US-206
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INSMED Inc
CENTRAL INDEX KEY: 0001104506
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 541972729
STATE OF INCORPORATION: VA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 700 US HIGHWAY 202/206
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
BUSINESS PHONE: 908-977-9900
MAIL ADDRESS:
STREET 1: 700 US HIGHWAY 202/206
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
FORMER COMPANY:
FORMER CONFORMED NAME: INSMED INC
DATE OF NAME CHANGE: 20000128
4
1
wk-form4_1717105441.xml
FORM 4
X0508
4
2024-05-28
0
0001104506
INSMED Inc
INSM
0001401017
Schaeffer Orlov S Nicole
700 US 202/206
BRIDGEWATER
NJ
08807
0
1
0
0
Chief People Strategy Officer
1
Common Stock
2024-05-28
4
M
0
27500
12.58
A
136260
D
Common Stock
2024-05-28
4
S
0
27500
49.53
D
108760
D
Stock Option (right to buy)
12.58
2024-05-28
4
M
0
27500
0
D
2024-06-02
Common Stock
27500
0
D
This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.
/s/ S. Nicole Schaeffer, by Michael A. Smith as Attorney-in-fact
2024-05-30